ERCC1-specific immunostaining in non-small-cell lung cancer [9]

New England Journal of Medicine

Volumn 357, Issue 15, 2007, Pages 1559-1561

  Olaussen, Ken A ^a   Fouret, Pierre ^b   Kroemer, Guido ^a  

^a INSERM   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPITOPE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; MONOCLONAL ANTIBODY; PARAFFIN; SMALL INTERFERING RNA; DIAGNOSTIC AGENT; DNA BINDING PROTEIN; ENDONUCLEASE; ERCC1 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

CANCER GROWTH; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LETTER; LUNG NON SMALL CELL CANCER; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA; ANTIBODY SPECIFICITY; EPITOPE MAPPING; GENE EXPRESSION; GENETICS; LUNG TUMOR; NOTE;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CARCINOMA, NON-SMALL-CELL LUNG; DNA-BINDING PROTEINS; ENDONUCLEASES; EPITOPE MAPPING; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS;

EID: 35248874798     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc072007     Document Type: Letter

References (5)

1. ERCC1 and non-small-cell lung cancer. N Engl J Med 2007;356:2538-41.
2. Olaussen KA, Dunant A, Fouret P, et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 2006;355:983-91.
3. Zheng Z, Chen T, Li X, Haura E, Sharma A, Bepler G. DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer. N Engl J Med 2007;356:800-8.
4. Chang IY, Kim MH, Kim HB, et al. Small interfering RNA induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin. Biochem Biophys Res Commun 2005;327:225-33.
5. Lan L, Hayashi T, Rabeya RM, et al. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis- diamminedichloroplatinum(II) in mammalian cells. DNA Repair (Amst) 2004;3:135-43.